Challenges and new technologies in adoptive cell therapy
P Zhang, G Zhang, X Wan - Journal of Hematology & Oncology, 2023 - Springer
Adoptive cell therapies (ACTs) have existed for decades. From the initial infusion of tumor-
infiltrating lymphocytes to the subsequent specific enhanced T cell receptor (TCR)-T and …
infiltrating lymphocytes to the subsequent specific enhanced T cell receptor (TCR)-T and …
The lipid basis of cell death and autophagy
Triglycerides, phospholipids, and cholesterol are prominent lipid types that serve diverse
biological functions. These lipids act as vital structural components of cell membranes …
biological functions. These lipids act as vital structural components of cell membranes …
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Y Bulliard, BS Andersson, MA Baysal… - Journal of hematology & …, 2023 - Springer
T cell differentiation is a highly regulated, multi-step process necessary for the progressive
establishment of effector functions, immunological memory, and long-term control of …
establishment of effector functions, immunological memory, and long-term control of …
Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer
X Zhou, G Wang, C Tian, L Du, EV Prochownik… - Nature …, 2024 - nature.com
Tumor cells reprogram their metabolism to produce specialized metabolites that both fuel
their own growth and license tumor immune evasion. However, the relationships between …
their own growth and license tumor immune evasion. However, the relationships between …
Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+ T cells
C Hu, W Qiao, X Li, Z Ning, J Liu, S Dalangood, H Li… - Cell metabolism, 2024 - cell.com
Tumors employ diverse strategies for immune evasion. Unraveling the mechanisms by
which tumors suppress anti-tumor immunity facilitates the development of immunotherapies …
which tumors suppress anti-tumor immunity facilitates the development of immunotherapies …
Nanotechnology reprogramming metabolism for enhanced tumor immunotherapy
Y Zhou, J Yuan, K Xu, S Li, Y Liu - ACS nano, 2024 - ACS Publications
Mutation burden, hypoxia, and immunoediting contribute to altered metabolic profiles in
tumor cells, resulting in a tumor microenvironment (TME) characterized by accumulation of …
tumor cells, resulting in a tumor microenvironment (TME) characterized by accumulation of …
Digitonin‐Loaded Nanoscale Metal–Organic Framework for Mitochondria‐Targeted Radiotherapy‐Radiodynamic Therapy and Disulfidptosis
The efficacy of radiotherapy (RT) is limited by inefficient X‐ray absorption and reactive
oxygen species generation, upregulation of immunosuppressive factors, and a reducing …
oxygen species generation, upregulation of immunosuppressive factors, and a reducing …
ATP6V0A1-dependent cholesterol absorption in colorectal cancer cells triggers immunosuppressive signaling to inactivate memory CD8+ T cells
TX Huang, HS Huang, SW Dong, JY Chen… - Nature …, 2024 - nature.com
Obesity shapes anti-tumor immunity through lipid metabolism; however, the mechanisms
underlying how colorectal cancer (CRC) cells utilize lipids to suppress anti-tumor immunity …
underlying how colorectal cancer (CRC) cells utilize lipids to suppress anti-tumor immunity …
Nutrients: Signal 4 in T cell immunity
JL Raynor, H Chi - Journal of Experimental Medicine, 2024 - rupress.org
T cells are integral in mediating adaptive immunity to infection, autoimmunity, and cancer.
Upon immune challenge, T cells exit from a quiescent state, followed by clonal expansion …
Upon immune challenge, T cells exit from a quiescent state, followed by clonal expansion …
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
H Zhang, S Li, D Wang, S Liu, T Xiao, W Gu, H Yang… - Biomarker …, 2024 - Springer
Tumor cells possess complex immune evasion mechanisms to evade immune system
attacks, primarily through metabolic reprogramming, which significantly alters the tumor …
attacks, primarily through metabolic reprogramming, which significantly alters the tumor …